Biopharma News

Aug 10, 2017
By BioPharm International Editors
Pfizer will invest $100 million to expand its manufacturing facilities in Sanford, North Carolina.
Aug 09, 2017
By BioPharm International Editors
Through its life-sciences business, MilliporeSigma, Merck KGaA will collaborate with Baylor College of Medicine to advance vaccine development for neglected and emerging diseases.
Aug 09, 2017
By BioPharm International Editors
FDA requests more detailed information on a post-marketing study for Dynavax’s hep-B vaccine, which will require an extended review time past its August 2017 PDUFA date.
Aug 07, 2017
By BioPharm International Editors
The Washington-headquartered biotech firm plans to use the newly purchased facility to produce antibodies for its current and future pipeline.
Aug 07, 2017
BioPharm International
By BioPharm International Editors
On August 3, 2017, Bristol-Myers Squibb (BMS) announced that it has agreed to acquire biotech firm, IFM Therapeutics, in a deal worth over $1 billion to develop BMS’ oncology pipeline.
Aug 04, 2017
By BioPharm International Editors
FDA has approved Mavyret (glecaprevir and pibrentasvir), a new molecular entity (NME), to treat chronic hepatitis C virus (HCV).
Aug 03, 2017
By BioPharm International Editors
FDA has approved Imbruvica (ibrutinib) to treat chronic graft versus host disease (cGVHD), a new indication for the anti-cancer drug.
Aug 01, 2017
By BioPharm International Editors
FDA advances biosimilars progress with acceptance of regulatory filing for biosimilar referencing a blockbuster biologic by Roche.
Aug 01, 2017
By BioPharm International Editors
FDA advances the progress of biosimilars with acceptance of regulatory filing for biosimilar referencing a blockbuster biologic by Roche.
Jul 31, 2017
By BioPharm International Editors
Partnership aims to develop new vaccine regimens against hep B and HIV by combining respective proprietary vaccine technologies.
native1_300x100
lorem ipsum